Study: Herceptin plus Tykerb help women with early breast cancer more than either drug alone SAN ANTONIO (AP) — New drug combinations are helping women with early breast cancer. Using two drugs that more precisely target tumors doubled the number of women whose cancer disappeared compared to those who had only one of the drugs, doctors reported Friday. However, another study added to the controversy over Avastin for breast cancer. Most women who received the drug for a few months before surgery fared no better than those who did not, it found. The studies were presented Friday at the San...

Glenda Kwek Australian experts have hailed as “remarkable” and “significant” a study that found taking aspirin daily cuts your risk of getting cancer, but cautioned the drug should not be regarded as a “magic bullet”. The British study, which was published in the medical journal The Lancet, analysed eight trials involving 25,570 patients, and found a daily dose of aspirin of less than 75 milligrams – about a quarter of an aspirin tablet – reduced cancer deaths by an average of 21 per cent during the studies and 34 per cent after five years. “It’s...

By Melinda Dodd The Cleveland Clinic announced a possible breakthrough—but is a breast cancer vaccine too good to be true? It’s something generations of women could only dream about: a cancer vaccine that keeps malignant cells from taking hold in the breast, and stops tumors in their tracks. Announced earlier this week by the Cleveland Clinic, the proposed breast-cancer vaccine contains a small amount of alpha-lactalbumin, a protein that researchers say is present in the majority of breast tumors. The vaccine is intended to create an immune response in your body that should help you beat...